Siliq
My Prescription
Payment
Select pharmacy
$3,937.28
$30.00 due at pharmacy
$3,937.28 - $30.00 = $3,907.28
$3,907.28 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$3,937.28
Print or send this coupon to your phone
AlbertsonsPowered byAbout Siliq
Drug Details
Brodalumab, marketed under the brand name Siliq, is a medication specifically designed to treat moderate to severe plaque psoriasis in patients who are eligible for systemic therapy or phototherapy and have not responded adequately to other treatments. It is administered as an under-the-skin injection, initially requiring a few starter doses, followed by a maintenance dose every two weeks. Brodalumab functions as a monoclonal antibody by binding to certain receptors in the body, effectively reducing the number of cells that contribute to inflammation. This mechanism helps decrease plaque thickness, redness, and scaling associated with psoriasis. Patients should be aware of the potential risk of mood-related side effects associated with Siliq and must enroll in the Risk Evaluation and Mitigation Strategies (REMS) program to access this medication. It is important to discuss with healthcare providers before starting Brodalumab to ensure it is the appropriate choice for your condition.
Price history for Siliq
1 Syringe, 1.5ML of 210MG/1.5ML
Average retail price for Siliq
Average SaveHealth price for Siliq
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Siliq dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1.5ML of 210MG/1.5ML | 1 Syringe | $3,937.28 | $3,937.28 |
| 1.5ML of 210MG/1.5ML | 2 Syringes | $7,866.56 | $3,933.28 |
| 1.5ML of 210MG/1.5ML | 3 Syringes | $11,795.84 | $3,931.95 |
Siliq FAQs
SILIQ is used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have not responded or have stopped responding to other systemic therapies.
Yes, SILIQ (brodalumab) is considered an immunosuppressant. It works by inhibiting the activity of interleukin-17, a protein involved in inflammatory and immune responses, which helps reduce inflammation and symptoms in conditions like plaque psoriasis.
The cost of SILIQ can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs offered by the manufacturer to help reduce out-of-pocket costs.
SILIQ (brodalumab) is considered effective for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Clinical trials have shown that a significant number of patients achieve clear or almost clear skin after 12 weeks of treatment. However, the effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to determine if SILIQ is the right treatment option for them.
SILIQ (brodalumab) is not approved for the treatment of psoriatic arthritis. It is approved for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.